Back
Arvinas Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
41
ARVN
Arvinas
Last Price:
25.37
Seasonality Move:
12.72%
Buy
68
EYPT
EyePoint Pharmaceuticals
Last Price:
8.86
Seasonality Move:
-10.5%
Sell
41
Arvinas (ARVN)
is a Sell
Is Arvinas a Buy, Sell or Hold?
- The current Arvinas [ARVN] share price is $25.05. The Score for ARVN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ARVN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $9.10. The Score for EYPT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARVN Stock Price Chart
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $9.10
The current trend is relatively stagnant and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
ARVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 46.9 | Sell |
| Chaikin Money Flow: | 23043 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.5 - 25.88) | Sell |
| Bollinger Bands (100): | (24.78 - 31.64) | Sell |
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 55.8 | Buy |
| Chaikin Money Flow: | -425112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.95 - 8.97) | Buy |
| Bollinger Bands (100): | (7.51 - 12.93) | Sell |
ARVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.94 | Buy |
| 20-day SMA: | 25.33 | Sell |
| 50-day SMA: | 26.47 | Sell |
| 200-day SMA: | 34.18 | Sell |
| 8-day EMA: | 25.04 | Buy |
| 20-day EMA: | 25.32 | Sell |
| 50-day EMA: | 26.36 | Sell |
| 200-day EMA: | 30.31 | Sell |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.36 | Buy |
| 20-day SMA: | 8.54 | Buy |
| 50-day SMA: | 8.88 | Buy |
| 200-day SMA: | 16.38 | Sell |
| 8-day EMA: | 8.56 | Buy |
| 20-day EMA: | 8.56 | Buy |
| 50-day EMA: | 9.1 | Sell |
| 200-day EMA: | 12.49 | Sell |
Arvinas Earnings Growth & ARVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.65 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.96 per share.
Arvinas Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EyePoint Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||